食品伙伴網(wǎng)訊  據(jù)歐盟食品安全局（EFSA）消息，2013年10月30日歐盟食品安全局就羥基蒽醌類衍生物改善腸道功能的健康聲稱發(fā)表意見。專家組經(jīng)過評估認(rèn)為，攝取羥基蒽醌類衍生物（hydroxyanthracene derivatives）可改善腸道功能。

    部分原文報(bào)道如下：

    Following an application from Vivatech, submitted for authorisation of a health claim pursuant to Article 13（5） of Regulation （EC） No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver an opinion on the scientific substantiation of a health claim related to hydroxyanthracene derivatives and improvement of bowel function.

    In relation to the restrictions of use, the Panel notes that stimulant laxatives should not be consumed continually for periods longer than one to two weeks. The use of stimulant laxatives for more than two weeks requires medical supervision. Long-term use of stimulant laxatives should be avoided owing to the danger of electrolyte imbalance, impaired function of the intestine, and dependence on laxatives. Stimulant laxatives should only be used if an effect on bowel function cannot be achieved by a change of diet or the administration of bulk forming agents.

    原文鏈接：http://www.efsa.europa.eu/en/efsajournal/pub/3412.htm